You are viewing an old version of this page. View the current version.
Compare with Current
View Page History
« Previous
Version 2
Next »
![](/download/attachments/327859/Safety%20Analytics%20Banner.jpg?version=1&modificationDate=1604050302040&api=v2)
This project team will create a White Paper with recommendations for treatment emergent definitions, with a focus on Phase 2-4 clinical trials. This White Paper will build upon a White Paper that outlines results from a survey on current practices, indicating variation that can likely be reduced. Recommendations will be based on the desired end-in-mind, and may or may not be consistent with current practices.
Project Leads: